Speaker illustration

Doctor Moaad Slieman

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

Cardiovascular disease and its association with outcomes in cancer patients treated with immune checkpoint inhibitors

Event: Heart Failure 2025

Topic: Cardio-Oncology

Session: Interventions to improve outcomes in cardio-oncology

Thumbnail

The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitor therapy

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardio-oncology: treatments and outcomes

Thumbnail

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardio-oncology: predicting adverse effects and prognosis

Thumbnail

Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer

Event: Heart Failure 2024

Topic: Cardio-Oncology

Session: ePosters in Cardiovascular disease in special populations (1)

Thumbnail